Description
CareStart COVID-19 Rapid Antigen Test - FDA EUA Approved
- Lateral flow assay
- No equipment required
- Rapid results within 10 minutes
- Minimally invasive specimen collection (nasopharyngeal swabs)
- POC setting (i.e. in patient care settings) by medical professionals
- Detects SARS-CoV-2 nucleocapsid protein antigen with ultra high performance
- Identify acute infection wit 88.4% sensitive and 100% specificity
Order Information
- 20 test/box
- 20 test devices
- 20 assay buffer
- 20 extraction vials and caps
- 20 specifimen collection swabs
- 1 positive and 1 negative control swabs
- 1 instructions for use
